SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-047019
Filing Date
2021-07-16
Accepted
2021-07-16 19:36:55
Documents
2
Period of Report
2021-07-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1501
2 POA DOCUMENT poa.txt EX-24.3_999381 3181
  Complete submission text file 0001209191-21-047019.txt   6072
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-595-2595
Atreca, Inc. (Issuer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E, SUITE 310 SEATTLE WA 98102
Business Address
Brady Stephen R (Reporting) CIK: 0001606241 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38935 | Film No.: 211096572